---
title: "Polygenic Pathways to Dementia: Premorbid Cognitive Level Versus Aging-Related Decline"
id: "medrxiv-5-joint-longitudinal-hazard-modeling-distinguishes-polygenic-effects-on-dementia"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-5-joint-longitudinal-hazard-modeling-distinguishes-polygenic-effects-on-dementia"
content_type: "clinical_feed_article"
specialty: "Neurology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.11.06.26367441v1?rss=1"
published_at: "2026-11-09T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Polygenic Pathways to Dementia: Premorbid Cognitive Level Versus Aging-Related Decline
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-5-joint-longitudinal-hazard-modeling-distinguishes-polygenic-effects-on-dementia
- **Specialty:** [Neurology](https://medichelpline.com/clinical-feed/neurology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.11.06.26367441v1?rss=1)
- **Published At:** 2026-11-09T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The investigators applied joint longitudinal-hazard models to 26 years of data from a multi-ancestry US sample of N = 11,518 adults to parse genetic pathways to dementia risk. - Models estimated how multi-ancestry **polygenic indices** (PGIs) for many established risk factors influenced dementia hazard via two mechanisms: lower premorbid cognitive function or steeper aging-related cognitive decline. - The cohort showed that **APOE e4** and PGIs for ADRD, type 2 diabetes, stroke, LDL cholesterol, and hearing loss were linked to dementia hazard primarily through accelerated longitudinal cognitive decline. - Data indicated PGIs for educational attainment, cognitive function, physical activity, BMI, smoking, loneliness, schizophrenia, and externalizing traits were associated with dementia hazard via lower premorbid cognitive levels. - The study team observed variation in some results by continental ancestry, indicating ancestry-specific differences in genetic effect patterns. - Authors noted the approach distinguishes genetic factors that may act through degenerative late-life processes from those that operate via premorbid cognitive differences, with implications for timing of interventions. - Data used are available by application to the Health and Retirement Study and the Lothian Birth Cohort; the University of Texas at Austin IRB provided ethical approval. - The article is a preprint and has not been peer-reviewed; the authors declared no competing interests.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=Nhasg688RVcWfODgxy6OJQuJNfyzDm3Gm6dF0Arneog-1794250759.7078688-1.2.1.1-i.QUjFVmDUr1FqQ6oTWJBV2au75CuiveVsdblEM_oiZKzTBYLkDQQqvCJ3Dfd3g7) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.11.06.26367441v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Joint Longitudinal Hazard Modeling Distinguishes Polygenic Effects on Dementia via Premorbid Cognitive Function and Aging-Related Decline [ View ORCID Profile](http://orcid.org/0000-0002-0231-1529)Margaret L Clapp Sullivan, Javier de la Fuente, [ View ORCID Profile](http://orcid.org/0000-0002-7551-1871)Janie Corley, [ View ORCID Profile](http://orcid.org/0000-0002-4941-5106)Sarah E Harris, Ian J Deary, [ View ORCID Profile](http://orcid.org/0000-0001-9797-2188)Tom C Russ, Simon R Cox, Elliot M Tucker-Drob doi: https://doi.org/10.64898/2026.11.06.26367441 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Margaret L Clapp Sullivan 1 Washington University School of Medicine; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Margaret%2BL%2BClapp%2BSullivan%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Clapp%20Sullivan%20ML&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMargaret%2BL%2BClapp%2BSullivan%2B) * [ORCID record for Margaret L Clapp Sullivan](http://orcid.org/0000-0002-0231-1529 "Open in new tab") * For correspondence: maggie.clapp@wustl.edu Javier de la Fuente 2 The University of Texas at Austin; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Javier%2Bde%2Bla%2BFuente%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=de%20la%20Fuente%20J&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AJavier%2Bde%2Bla%2BFuente%2B) Janie Corley 3 University of Edinburgh; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Janie%2BCorley%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Corley%20J&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AJanie%2BCorley%2B) * [ORCID record for Janie Corley](http://orcid.org/0000-0002-7551-1871 "Open in new tab") Sarah E Harris 3 University of Edinburgh; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Sarah%2BE%2BHarris%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Harris%20SE&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ASarah%2BE%2BHarris%2B) * [ORCID record for Sarah E Harris](http://orcid.org/0000-0002-4941-5106 "Open in new tab") Ian J Deary 3 University of Edinburgh; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Ian%2BJ%2BDeary%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Deary%20IJ&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AIan%2BJ%2BDeary%2B) Tom C Russ 3 University of Edinburgh; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Tom%2BC%2BRuss%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Russ%20TC&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ATom%2BC%2BRuss%2B) * [ORCID record for Tom C Russ](http://orcid.org/0000-0001-9797-2188 "Open in new tab") Simon R Cox 3 University of Edinburgh; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Simon%2BR%2BCox%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Cox%20SR&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ASimon%2BR%2BCox%2B) Elliot M Tucker-Drob 4 University of Texas at Austin * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Elliot%2BM%2BTucker-Drob%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Tucker-Drob%20EM&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AElliot%2BM%2BTucker-Drob%2B) * [Abstract](https://www.medrxiv.org/content/10.64898/2026.11.06.26367441v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1340565/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.11.06.26367441v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1340565/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.11.06.26367441v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1340565/1) * [Supplementary material](https://www.medrxiv.org/content/10.64898/2026.11.06.26367441v1.supplementary-material)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_data/node:1340565/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.11.06.26367441v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1340565/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.11.06.26367441v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1340565/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Alzheimers disease and related dementias (AD/ADRD) are clinical disorders characterized by declines in cognitive function to levels at which everyday living is meaningfully impaired. Genetic variants may confer risk for AD/ADRD by way of steeper rates of aging-related cognitive declines or their association with lower premorbid levels of cognitive function that place individuals closer to a clinically severe threshold of cognitive function. We applied joint longitudinal-hazard models to 26-year data from an ancestrally diverse US sample of N = 11,518 adults to estimate effects of multi-ancestry polygenic indices (PGIs) for a range of established risk factors on dementia hazard and the degree they operate via premorbid cognitive function and longitudinal cognitive decline. APOE e4 and PGIs for ADRD, type 2 diabetes, stroke, LDL cholesterol, and hearing loss operated via rate of change, whereas PGIs for educational attainment, cognitive function, physical activity, BMI, smoking, loneliness, schizophrenia, and externalizing were associated with dementia hazard via premorbid differences in cognitive function. Some results varied by continental ancestry. Our implementation of joint longitudinal-hazard models allowed us to distinguish how different genetic risk factors for AD/ADRD operate via degenerative processes that might be therapeutically targeted during later life and via premorbid levels of cognitive function that would require intervention earlier in the life course. ### Competing Interest Statement The authors have declared no competing interest. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: IRB of University of Texas at Austin gave ethical approval for this work. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability Data used in the present study are available by application to the Health and Retirement Study and Lothian Birth Cohort. ## Funder Information Declared National Institutes of Health, https://ror.org/01cwqze88, R01AG073593, T32DA007261, P2CHD042849, P30AG066614 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY-NC-ND 4.0 International license](http://creativecommons.org/licenses/by-nc-nd/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.11.06.26367441v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.11.06.26367201v1 "Donepezil, galantamine and rivastigmine and progression to memantine add-on therapy in Alzheimer's disease: a nationwide cohort study emulating a target trial in the Brazilian Unified Health System")[Next ](https://www.medrxiv.org/content/10.64898/2026.11.06.26367452v1 "Metabolome-wide Association Study of Bronchopulmonary Dysplasia in Extremely Premature Infants") Posted November 09, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.11.06.26367441v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/11/09/2026.11.06.26367441.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.11.06.26367441v1#p-5) [Supplementary Material ](https://www.medrxiv.org/content/10.64898/2026.11.06.26367441v1.supplementary-material) [ Data/Code](https://www.medrxiv.org/content/early/2026/11/09/2026.11.06.26367441.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Joint Longitudinal Hazard Modeling Distinguishes Polygenic Effects on Dementia via Premorbid Cognitive Function and Aging-Related Decline Margaret L Clapp Sullivan, Javier de la Fuente, Janie Corley, Sarah E Harris, Ian J Deary, Tom C Russ, Simon R Cox, Elliot M Tucker-Drob medRxiv 2026.11.06.26367441; doi: https://doi.org/10.64898/2026.11.06.26367441 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.06.26367441v1%26text%3DJoint%2520Longitudinal%2520Hazard%2520Modeling%2520Distinguishes%2520Polygenic%2520Effects%2520on%2520Dementia%2520via%2520Premorbid%2520Cognitive%2520Function%2520and%2520Aging-Related%2520Decline "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.06.26367441v1%26t%3DJoint%2520Longitudinal%2520Hazard%2520Modeling%2520Distinguishes%2520Polygenic%2520Effects%2520on%2520Dementia%2520via%2520Premorbid%2520Cognitive%2520Function%2520and%2520Aging-Related%2520Decline "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.06.26367441v1%26title%3DJoint%2520Longitudinal%2520Hazard%2520Modeling%2520Distinguishes%2520Polygenic%2520Effects%2520on%2520Dementia%2520via%2520Premorbid%2520Cognitive%2520Function%2520and%2520Aging-Related%2520Decline%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.06.26367441v1%26title%3DJoint%2520Longitudinal%2520Hazard%2520Modeling%2520Distinguishes%2520Polygenic%2520Effects%2520on%2520Dementia%2520via%2520Premorbid%2520Cognitive%2520Function%2520and%2520Aging-Related%2520Decline "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.11.06.26367441) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.64898/2026.11.06.26367441v1&count=horizontal&via=&text=Joint%20Longitudinal%20Hazard%20Modeling%20Distinguishes%20Polygenic%20Effects%20on%20Dementia%20via%20Premorbid%20Cognitive%20Function%20and%20Aging-Related%20Decline&counturl=www.medrxiv.org/content/10.64898/2026.11.06.26367441v1 "Tweet This") Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (638) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (918) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (351) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (5008) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (496) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (428) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (676) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1694) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (16269) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (36) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1241) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (7284) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (752) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1093) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (5293) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1468) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1833) * [Hematology](https://www.medrxiv.org/collection/hematology) (599) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1382) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16492) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1203) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (700) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (156) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (752) * [Neurology](https://www.medrxiv.org/collection/neurology) (7601) * [Nursing](https://www.medrxiv.org/collection/nursing) (378) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1130) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1296) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (1040) * [Oncology](https://www.medrxiv.org/collection/oncology) (3749) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1093) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (410) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (466) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (502) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (143) * [Pathology](https://www.medrxiv.org/collection/pathology) (721) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1861) * [Pharmacology and Therapeutics](https://www.medrxiv.org/collection/pharmacology-and-therapeutics) (756) * [Primary Care Research](https://www.medrxiv.org/collection/primary-care-research) (786) * [Psychiatry and Clinical Psychology](https://www.medrxiv.org/collection/psychiatry-and-clinical-psychology) (6135) * [Public and Global Health](https://www.medrxiv.org/collection/public-and-global-health) (9994) * [Radiology and Imaging](https://www.medrxiv.org/collection/radiology-and-imaging) (2533) * [Rehabilitation Medicine and Physical Therapy](https://www.medrxiv.org/collection/rehabilitation-medicine-and-physical-therapy) (1521) * [Respiratory Medicine](https://www.medrxiv.org/collection/respiratory-medicine) (12
## Related Clinical Research

- [Retinal changes on OCT may predict atrial fibrillation risk years earlier](https://medichelpline.com/clinical-feed/medical-news-today-0-how-changes-in-the-eyes-may-help-spot-afib-risk-years-early.md)
- [U.S. POINTER: Structured lifestyle program slows brain aging and cardiometabolic risk over 24 mont](https://medichelpline.com/clinical-feed/medical-news-today-0-combining-physical-mental-and-social-habits-slows-brain-aging-in-2-year-trial.md)
- [Exercise Timing and Cognition in Older Adults with Type 2 Diabetes and MCI: MRI RCT Protocol](https://medichelpline.com/clinical-feed/plos-one-21-effects-and-mechanisms-of-exercise-timing-on-cognitive-function-in-older-type-2.md)
- [High-resolution map of the basal ganglia reveals cell types tied to Parkinson’s and schizophrenia](https://medichelpline.com/clinical-feed/stat-news-1-stat-scientists-debut-map-of-basal-ganglia-a-key-brain-region-involved-in-an.md)
- [Standardized Video-based Asynchronous Neurological Examination (VANE) Implemented Across 25 Sites](https://medichelpline.com/clinical-feed/medrxiv-0-implementation-of-a-standardized-video-based-asynchronous-neurological.md)

## Navigation
- [← Back to Neurology Feed](https://medichelpline.com/clinical-feed/neurology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.